HOW TO OPTIMALLY SEQUENCE AVAILABLE THERAPY LINES IN ADVANCED PROSTATE CANCER

Optimal sequencing of available therapy lines in patients with advanced prostate cancer often poses quite a challenge. The guidelines are sometimes equivocal and clinical trial data are not always applicable to a particular patient. There is a difference in availability of therapy options throughout...

Descripción completa

Detalles Bibliográficos
Autores principales: Antunac, Katarina, Beketić-Orešković, Lidija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022401/
https://www.ncbi.nlm.nih.gov/pubmed/36938556
http://dx.doi.org/10.20471/acc.2022.61.s3.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022401/
https://www.ncbi.nlm.nih.gov/pubmed/36938556
http://dx.doi.org/10.20471/acc.2022.61.s3.5

Ejemplares similares